These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 1728716
21. [Beneficial effects of Tong-xin-luo (herb) on myocardial no-reflow after acute myocardial infarction and reperfusion: experiment of mini-swine model]. Yang YJ, Zhao JL, Jing ZC, Wu YJ, You SJ, Yang WX, Meng L, Tian Y, Chen JL, Gao RL, Chen ZJ. Zhonghua Yi Xue Za Zhi; 2005 Apr 06; 85(13):883-8. PubMed ID: 16029525 [Abstract] [Full Text] [Related]
22. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Vander Heide RS, Reimer KA. Cardiovasc Res; 1996 May 06; 31(5):711-8. PubMed ID: 8763400 [Abstract] [Full Text] [Related]
23. Reduction of infarct size with coronary venous retroperfusion. Lazar HL, Haan CK, Yang X, Rivers S, Bernard S, Shemin RJ. Circulation; 1992 Nov 06; 86(5 Suppl):II352-7. PubMed ID: 1358475 [Abstract] [Full Text] [Related]
24. Preconditioning the heart by repeated stunning improves myocardial salvage. Flack JE, Kimura Y, Engelman RM, Rousou JA, Iyengar J, Jones R, Das DK. Circulation; 1991 Nov 06; 84(5 Suppl):III369-74. PubMed ID: 1934432 [Abstract] [Full Text] [Related]
25. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit. Hale SL, Kloner RA. J Cardiovasc Pharmacol Ther; 2008 Sep 06; 13(3):226-32. PubMed ID: 18625805 [Abstract] [Full Text] [Related]
26. Immediate functional benefits after controlled reperfusion during surgical revascularization for acute coronary occlusion. Beyersdorf F, Sarai K, Maul FD, Wendt T, Satter P. J Thorac Cardiovasc Surg; 1991 Dec 06; 102(6):856-66. PubMed ID: 1801796 [Abstract] [Full Text] [Related]
27. Amelioration of postischemic stunning by deferoxamine-blood cardioplegia. Illes RW, Silverman NA, Krukenkamp IB, del Nido PJ, Levitsky S. Circulation; 1989 Nov 06; 80(5 Pt 2):III30-5. PubMed ID: 2805305 [Abstract] [Full Text] [Related]
28. Left atrium-to-femoral artery bypass: effectiveness in reduction of acute experimental myocardial infarction. Catinella FP, Cunningham JN, Glassman E, Laschinger JC, Baumann FG, Spencer FC. J Thorac Cardiovasc Surg; 1983 Dec 06; 86(6):887-96. PubMed ID: 6645591 [Abstract] [Full Text] [Related]
29. Adjunctive left ventricular unloading during myocardial reperfusion plays a major role in minimizing myocardial infarct size. Laschinger JC, Grossi EA, Cunningham JN, Krieger KH, Baumann FG, Colvin SB, Spencer FC. J Thorac Cardiovasc Surg; 1985 Jul 06; 90(1):80-5. PubMed ID: 4010324 [Abstract] [Full Text] [Related]
30. Limitation of myocardial infarct size after surgical reperfusion for acute coronary occlusion. Wood D, Roberts C, Van Devanter SH, Kloner R, Cohn LH. J Thorac Cardiovasc Surg; 1982 Sep 06; 84(3):353-8. PubMed ID: 7109667 [Abstract] [Full Text] [Related]
31. Reversal of reperfusion injury after ischemic arrest with pressure-controlled intermittent coronary sinus occlusion. Lazar HL, Rajaii A, Roberts AJ. J Thorac Cardiovasc Surg; 1988 Apr 06; 95(4):637-42. PubMed ID: 3352298 [Abstract] [Full Text] [Related]
32. Studies of controlled reperfusion after ischemia. XX. Reperfusate composition: detrimental effects of initial asanguineous cardioplegic washout after acute coronary occlusion. Acar C, Partington MT, Buckberg GD. J Thorac Cardiovasc Surg; 1991 Feb 06; 101(2):294-302. PubMed ID: 1992240 [Abstract] [Full Text] [Related]
33. Studies of controlled reperfusion after ischemia. XVII. Reperfusion conditions: controlled reperfusion through an internal mammary artery graft--a new technique emphasizing fixed pressure versus fixed flow. Acar C, Partington MT, Buckberg GD. J Thorac Cardiovasc Surg; 1990 Nov 06; 100(5):724-36. PubMed ID: 2232835 [Abstract] [Full Text] [Related]
34. Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: an experimental study. Pierrakos CN, Bonios MJ, Drakos SG, Charitos EI, Tsolakis EJ, Ntalianis A, Nanas SN, Charitos CE, Nanas JN, Terrovitis JV. Artif Organs; 2011 Sep 06; 35(9):867-74. PubMed ID: 21726241 [Abstract] [Full Text] [Related]
35. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC. Circulation; 1989 Dec 06; 80(6):1816-27. PubMed ID: 2598440 [Abstract] [Full Text] [Related]
36. Reduction of infarct size by systemic amino acid supplementation during reperfusion. Engelman RM, Rousou JA, Flack JE, Iyengar J, Kimura Y, Das DK. J Thorac Cardiovasc Surg; 1991 May 06; 101(5):855-9. PubMed ID: 1673733 [Abstract] [Full Text] [Related]
37. Influence of leukopenia on collateral flow, reperfusion flow, reflow ventricular fibrillation, and infarct size in dogs. de Lorgeril M, Basmadjian A, Lavallée M, Clément R, Millette D, Rousseau G, Latour JG. Am Heart J; 1989 Mar 06; 117(3):523-32. PubMed ID: 2919531 [Abstract] [Full Text] [Related]
38. Preconditioning does not attenuate myocardial stunning. Ovize M, Przyklenk K, Hale SL, Kloner RA. Circulation; 1992 Jun 06; 85(6):2247-54. PubMed ID: 1591839 [Abstract] [Full Text] [Related]
39. Alleviation of myocardial stunning by leukocyte and platelet depletion. Westlin W, Mullane KM. Circulation; 1989 Dec 06; 80(6):1828-36. PubMed ID: 2598441 [Abstract] [Full Text] [Related]
40. Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size. Lee R, Nitta T, Schmid RA, Schuessler RB, Harris KM, Gay WA. Ann Thorac Surg; 1998 May 06; 65(5):1353-9. PubMed ID: 9594866 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]